Concepedia

Mirosław Śmietański

MŚ

Statistics

Publications

6

Citations

253

H-Index

6

Active since

2014

Affiliations

University of Warsaw(Current)

United Technologies Corporation (Poland)

OncoArendi Therapeutics (Poland)

College of Europe, Warsaw

Mirosław Śmietański is an author at University of Warsaw specializing in medicine, high-throughput screening, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2014–2024

6

Publications

6

Structural analysis of human 2′-O-ribose methyltransferases involved in mRNA cap structure formation

Mirosław Śmietański, Maria Fernanda de Paula Werner, Elżbieta Purta et al. · Nature Communications · 2014 · 104 citations · Full text

Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression

Dominika Strzelecka, Mirosław Śmietański, Pawel J. Sikorski et al. · RNA · 2020 · 60 citations · Full text

Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase

Renata Kasprzyk, Tomasz Śpiewla, Mirosław Śmietański et al. · Antiviral Research · 2021 · 34 citations · Full text

Trinucleotide mRNA Cap Analogue <i>N</i>6-Benzylated at the Site of Posttranscriptional <sup>m6</sup>A<sub>m</sub> Mark Facilitates mRNA Purification and Confers Superior Translational Properties In Vitro and In Vivo

Marcin Warmiński, Edyta Trepkowska, Mirosław Śmietański et al. · Journal of the American Chemical Society · 2024 · 28 citations · Full text

Direct High‐Throughput Screening Assay for mRNA Cap Guanine‐N7 Methyltransferase Activity

Renata Kasprzyk, Mateusz Fido, Adam Mamot et al. · Chemistry - A European Journal · 2020 · 14 citations · Full text

, , +15

1–5 of 6